Cardiol Therapeutics Inc.

NASDAQ:CRDL

1.25 (USD) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Revenue 000.0790000
Cost of Revenue 0.2480.2200.230.1510.0910.053
Gross Profit -0.248-0.220.079-0.23-0.151-0.091-0.053
Gross Profit Ratio 0010000
Reseach & Development Expenses 14.22418.96210.8710.5153.531.5330.441
General & Administrative Expenses 15.56122.37427.8739.94610.4475.871.101
Selling & Marketing Expenses 0000000
SG&A 15.56122.37427.8739.94610.4475.871.101
Other Expenses 00.1640.1120.0070.2990-0.061
Operating Expenses 29.78641.33638.74420.6914.1287.4941.595
Operating Income -29.786-50.339-45.473-20.606-13.584-7.39-1.589
Operating Income Ratio 00-577.3630000
Total Other Income Expenses Net 1.65710.4057.027-0.034-1.941-8.503-0.072
Income Before Tax -28.128-30.931-31.638-20.641-13.684-15.894-1.661
Income Before Tax Ratio 00-401.7040000
Income Tax Expense 0-10.241-6.9140.0070.2990.6630.061
Net Income -28.128-30.931-31.638-20.641-13.684-15.894-1.661
Net Income Ratio 00-401.7040000
EPS -0.44-0.49-0.73-0.69-0.53-1.03-0.073
EPS Diluted -0.44-0.49-0.73-0.69-0.53-1.03-0.073
EBITDA -29.59-41.156-38.444-20.461-11.767-7.299-1.504
EBITDA Ratio 00-574.5650000